Search results for "biliary"

showing 10 items of 238 documents

Endoscopic treatment of the "sump syndrome" after choledochoduodenostomy: a new technique using an amplatzer septal occluder.

2006

A 58-year-old male patient had been suffering for 35 years from recurrent cholangitis, biliary sludge and infection-induced stone formation after open cholecystectomy because of empyema of the gallbladder and severe acute and delayed postoperative complications. The pathophysiological origin of this chronic "sump syndrome" was a choledochoduodenostomy which had been performed prophylactically at the time of the initial operation. The patient agreed to an experimental treatment option with use of an Amplatzer atrial-septal defect (ASD) occluder for closure of the symptomatic choledochoduodenal fistula. The double-disc occluder was introduced through a 9 French diameter and 90 cm long sheath …

Malemedicine.medical_specialtyPostcholecystectomy syndromeFistulamedicine.medical_treatmentSump SyndromeProsthesis DesignProsthesis ImplantationLiver Function TestsmedicineHumansBiliary sludgeDuodenoscopyCholangiopancreatography Endoscopic RetrogradeCommon bile ductbusiness.industryGallbladderGastroenterologyMiddle Agedmedicine.diseaseEmpyemaSurgerymedicine.anatomical_structureTreatment OutcomeTherapeutic endoscopyCholedochostomyFluoroscopybusinessPostcholecystectomy SyndromeFollow-Up StudiesZeitschrift fur Gastroenterologie
researchProduct

Efficacy and safety of direct transnasal cholangioscopy with standard ultraslim endoscopes: results of a large cohort study.

2013

Background Direct cholangioscopy (DC) with ultraslim endoscopes and free-hand cannulation of the common bile duct (CBD) is a promising technique for evaluating and treating cholangiopathy. However, its safety and success rates are as yet unclear. Objective To evaluate the overall success rates and adverse events with the procedure. Design Single-center, prospective cohort study; 12 patients retrospectively enrolled. Setting Academic tertiary referral center. Patients A total of 100 DC procedures in 84 patients with biliary disease were evaluated prospectively. Interventions DC performed with the patient under conscious sedation. Main Outcome Measurements Overall success rates and adverse ev…

Malemedicine.medical_specialtySedationOperative TimeConscious SedationNoseBalloonBiliary diseaseCholangiocarcinomamedicineHumansRadiology Nuclear Medicine and imagingEndoscopy Digestive SystemProspective StudiesProspective cohort studyAdverse effectAgedAged 80 and overCommon bile ductbusiness.industryBile ductGastroenterologyMiddle Agedmedicine.diseaseLarge cohortSurgerymedicine.anatomical_structureBile Ducts IntrahepaticCholedocholithiasisBile Duct NeoplasmsFemalemedicine.symptombusinessGastrointestinal endoscopy
researchProduct

Effect of different doses of ursodeoxycholic acid in chronic liver disease

1989

Recent clinical studies have indicated that ursodeoxycholic acid (ursodiol), administered at dosages ranging between 10 and 15 mg/kg/day, improves liver function indices in both cholestatic and inflammatory chronic liver diseases. These dosages would be considered high for the use of ursodiol in gallstone dissolution therapy. To investigate the dose-response relationship to ursodiol administration, we planned a few studies in patients with primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and chronic hepatitis (CH). Patients with PBC were subdivided into two groups on the basis of their serum bilirubin values, with 2 mg/dl as the dividing line. Ursodiol was given at dos…

Malemedicine.medical_specialtyTime FactorsPhysiologyBilirubinCholangitis SclerosingChronic liver diseaseGastroenterologyPrimary sclerosing cholangitisRandom Allocationchemistry.chemical_compoundPrimary biliary cirrhosisLiver Function TestsInternal medicinemedicineBileHumansHepatitis ChronicHepatitisDose-Response Relationship Drugmedicine.diagnostic_testLiver Cirrhosis Biliarybusiness.industryUrsodeoxycholic AcidGastroenterologyBilirubinMiddle AgedLipid Metabolismmedicine.diseaseUrsodeoxycholic acidchemistryFemaleLiver functionLiver function testsbusinessDeoxycholic Acidmedicine.drugDigestive Diseases and Sciences
researchProduct

Trends in the incidence and management of biliary tract cancer: a French population-based study.

2011

The trends in incidence and management of biliary tract cancer (BTC) were investigated in a well-defined French population over a 30-year period (1976-2005).Data were obtained from the Burgundy digestive cancer registry. Age-standardised incidence rates and trends in incidence were determined. Treatment and stage at diagnosis were also investigated. Five-year survival rates were calculated.Six hundred and fifteen cases of BTC were recorded. There was no significant change in BTC incidence over the 30-year period. For extrahepatic BTC age-standardised incidence rates were 1.1/100,000 for 1976-80 and 2001-2005. These rates were respectively 0.3 and 0.2/100,000 for intrahepatic BTC. The propor…

Malemedicine.medical_specialtyTime FactorsPopulationGastroenterologyBile duct cancerInternal medicineEpidemiologymedicineHumanseducationSurvival rateAgedNeoplasm Stagingeducation.field_of_studyBiliary tract cancerHepatologyRelative survivalbusiness.industryIncidence (epidemiology)Incidencemedicine.diseasePopulation based studySurvival RateBiliary Tract NeoplasmsFemaleFrancebusinessJournal of hepatology
researchProduct

A 9-Year Retained T-Tube Fragment Encased within a Stone as a Rare Cause of Jaundice

2008

Biliary diseases such as cholangitis may cause jaundice and liver damage. Here, we report on an unusual cause of jaundice in an 84-year-old man 9 years after cholecystectomy. Ultrasound analysis revealed unclear extrahepatic cholestasis and subsequent ERCP showed a large biliary stone sourrounding a T-tube fragment that had remained in the common bile duct for more than 9 years after surgery. The tip of the drainage and the stone could be successfully removed using Dormia baskets. This case suggests that plastic material accidentally left in the common bile duct favours the development of large biliary casts when present over long periods of time.

Malemedicine.medical_specialtymedicine.medical_treatmentBile Duct DiseasesExtrahepatic CholestasisGastroenterologyInternal medicinemedicineHumansCholecystectomyLiver damageAged 80 and overCommon bile ductbusiness.industryForeign-Body ReactionGastroenterologyJaundiceSurgeryJaundice ObstructiveTreatment OutcomeBiliary stonemedicine.anatomical_structureStentsCholecystectomymedicine.symptombusinessZeitschrift für Gastroenterologie
researchProduct

Management of retained bile duct stones: a prospective open trial comparing extracorporeal and intracorporeal lithotripsy.

1996

Abstract Background: Endoscopic management of common bile duct stones has become the approach of choice, especially in patients with high surgical risk. Problems are encountered if there are large stones or a duct stenosis. For these difficult stones, shock wave technology serves as an alternative to surgical intervention. Methods: A total of 125 patients with common bile duct stones in whom conventional endoscopic treatment had failed were selected and treated either by extracorporeal piezoelectric lithotripsy (ESWL, n=79) or intracorporeal electrohydraulic lithotripsy (EHL, n=46). The average age of our patients was 70 years. Results: In the ESWL group visualization of the stones by ultra…

Malemedicine.medical_specialtymedicine.medical_treatmentGallstonesLithotripsyExtracorporealCholangiographyLithotripsymedicineHumansRadiology Nuclear Medicine and imagingEndoscopy Digestive SystemProspective StudiesAgedCommon bile ductmedicine.diagnostic_testBile ductbusiness.industryGastroenterologyGallstonesmedicine.diseaseLaser lithotripsySurgerymedicine.anatomical_structureTreatment OutcomeBiliary tractFemalebusinessCholangiographyGastrointestinal endoscopy
researchProduct

Prospective, randomized, single-center trial comparing 3 different 10F plastic stents in malignant mid and distal bile duct strictures.

2003

Abstract Background: The aim of this study was to determine whether patency rates differ with respect to the material, design, and surface texture of 3 different plastic stents. Methods: A total of 120 patients (median age 70.5 years; interquartile range 62-78 years) with malignant mid or distal bile duct strictures, seen between March 1996 and May 1999, were prospectively randomized to receive a 10F polyurethane stent, a Teflon Tannenbaum stent, or a hydrophilic hydromer-coated polyurethane stent. The primary study outcome measure was the interval between stent insertion and the first episode of clogging (or the presence of jaundice at death without stent exchange). All 3 types of stent we…

Malemedicine.medical_specialtymedicine.medical_treatmentPolyurethanesCholestasis IntrahepaticConstriction PathologicSingle CenterProsthesis DesignRisk Assessmentlaw.inventionRandomized controlled trialCoated Materials BiocompatiblelawInterquartile rangemedicineHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesProspective StudiesAgedFirst episodeCholangiopancreatography Endoscopic Retrogrademedicine.diagnostic_testEquipment Safetybusiness.industryGastroenterologyStentMiddle Agedequipment and suppliesmedicine.diseaseSurvival AnalysisEndoscopySurgeryProsthesis FailureStenosissurgical procedures operativeTreatment OutcomeBile Duct NeoplasmsBiliary tractFemaleStentsRadiologybusinessFollow-Up StudiesGastrointestinal endoscopy
researchProduct

Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control stud…

2007

OBJECTIVES: To identify risk factors of carcinoma of the extrahepatic biliary tract in men. METHODS: Newly diagnosed and histologically confirmed patients, 35-70 years old, were interviewed between 1995 and 1997 in Denmark, Sweden, France, Germany and Italy. Population controls were frequency-matched by age and region. Adjusted odds ratios and 95%-confidence intervals were estimated by logistic regression. RESULTS: The analysis included 153 patients and 1421 controls. The participation proportion was 71% for patients and 61% for controls. Gallstone disease was corroborated as a risk factor for extrahepatic biliary tract carcinoma in men (odds ratio 2.49; 95% confidence interval 1.32-4.70), …

MaleobesityEtiologyEpidemiologyMedizinGastroenterologyBody Mass Index0302 clinical medicineBile Ducts ExtrahepaticCholelithiasisRisk FactorsMedicineAlcohol consumption2. Zero hungerBiliary tract neoplasmeducation.field_of_studySmokingGastroenterologyCase-control studyMenGallstonesMiddle Agedmedical history3. Good healthBiliary tract carcinomaBiliary Tract Neoplasms030220 oncology & carcinogenesisMedical history030211 gastroenterology & hepatologyGallbladder NeoplasmsepidemiologyGallbladder carcinomaAdultmedicine.medical_specialtyAmpulla of Vateralcohol consumptioncase-control studyetiologyPopulationCommon Bile Duct Neoplasmsmensmoking03 medical and health sciencesInternal medicinesmoking.HumansObesityRisk factoreducationLife StyleAgedbiliary tract carcinomaHepatologybusiness.industryCase-control studyOdds ratiomedicine.diseaseConfidence interval[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCase-Control Studies[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiegallbladder carcinomabusinessBody mass index
researchProduct

Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance.

2021

Abstract Background There is strong evidence that portal vein tumor thrombosis (PVTT) is associated with poor survival in patients with hepatocellular carcinoma (HCC). However, data regarding the clinical significance of hepatic vein tumor thrombosis (HVTT) is rare, particularly in Western patients. Objective To determine the HVTT prevalence in a Western patient population and its impact on survival. Methods We included 1310 patients with HCC treated in our tertiary referral center between January 2005 and December 2016. HVTT and PVTT were diagnosed with contrast‐enhanced cross‐sectional imaging. Overall survival (OS) was calculated starting from the initial HCC diagnosis, and in a second s…

Maletumor thrombosismedicine.medical_specialtytumorCarcinoma HepatocellularKaplan-Meier EstimateHepatic VeinsGastroenterologysurvival03 medical and health sciences0302 clinical medicineInternal medicineGermanymedicinePrevalenceHumansIn patientClinical significanceNeoplasm InvasivenessRisk factorVeinAgedRetrospective StudiesVenous Thrombosishepatic vein thrombosisbusiness.industryPortal VeinAdvanced stageLiver NeoplasmsGastroenterologyhepatocellular carcinomaMiddle Agedmedicine.diseaseThrombosismedicine.anatomical_structureOncology030220 oncology & carcinogenesisHepatocellular carcinomaMultivariate AnalysisReferral center030211 gastroenterology & hepatologyFemaleOriginal ArticleHepatobiliarybusinessUnited European gastroenterology journal
researchProduct

Significant autoimmune markers of autoimmune liver disorders: Current status

1987

Microbiology (medical)Hepatitisbusiness.industryBiochemistry (medical)Clinical BiochemistryPublic Health Environmental and Occupational HealthAutoantibodyHematologymedicine.disease_causemedicine.diseaseAutoimmunityMedical Laboratory TechnologyPrimary biliary cirrhosisImmunologymedicineImmunology and AllergybusinessJournal of Clinical Laboratory Analysis
researchProduct